Transforming the natural course of infantile onset thymidine kinase 2 deficiency through early nucleoside replacement therapy.

Akinci G, Sardarzada J, Topaloglu H

Open source

DOI
10.1177/22143602261433223
Published
2026 Apr 7
Container
Journal of neuromuscular diseases
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/22143602261433223,
  title = {Transforming the natural course of infantile onset thymidine kinase 2 deficiency through early nucleoside replacement therapy.},
  author = {Akinci G and Sardarzada J and Topaloglu H},
  year = {2026},
  journal = {Journal of neuromuscular diseases},
  doi = {10.1177/22143602261433223},
  url = {https://doi.org/10.1177/22143602261433223}
}

RIS

TY  - JOUR
TI  - Transforming the natural course of infantile onset thymidine kinase 2 deficiency through early nucleoside replacement therapy.
AU  - Akinci G
AU  - Sardarzada J
AU  - Topaloglu H
PY  - 2026
JO  - Journal of neuromuscular diseases
DO  - 10.1177/22143602261433223
UR  - https://doi.org/10.1177/22143602261433223
ER  - 

APA

G, A., J, S., & H, T. (2026). Transforming the natural course of infantile onset thymidine kinase 2 deficiency through early nucleoside replacement therapy.. Journal of neuromuscular diseases. https://doi.org/10.1177/22143602261433223

Source records